CVS Group plc
CVS Group plc
Your view on CVSGF
Overview
What the company does, where it operates, and who runs it.
About CVS Group plc
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Richard William Mark Fairman
- Headquarters
- CVS House, Diss, GB
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Richard William Mark Fairman
- Headquarters
- CVS House, Diss, GB
CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail. It operates animal veterinary practices and complementary veterinary diagnostic businesses.
The company also provides pet cremation and clinical waste services for veterinary practices. In addition, it operates Animed Direct, an online retail business that sells prescription and non-prescription medicines, pet foods, and other pet care products; and an online dispensary.
Further, the company provides burial grounds; veterinary instrumentation supply; and property development services. It owns 472 veterinary practices, 3 laboratories, and 7 crematoria in the United Kingdom, the Netherlands, and the Republic of Ireland. CVS Group plc was founded in 1999 and is headquartered in Diss, the United Kingdom.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for CVS Group plc, and the rating behind it. CVSGF last traded at $16.22, 58.9× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for CVS Group plc. Starting points for CVS Group plc: P/E 58.9, EPS $0.22, beta 1.05 — an Medical - Care Facilities name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for CVS Group plc. CVS Group plc does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for CVS Group plc. Trailing twelve-month EPS for CVS Group plc stands at $0.22. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for CVS Group plc. CVS Group plc has reported as a listed company since 2018. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
CVS Group plc valued side by side against its closest peers. CVS Group plc is measured against Medical - Care Facilities peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold CVS Group plc, and how their positions are changing. At a $1.14B market value, institutional positions materially move CVS Group plc's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by CVS Group plc executives and directors. Shares of CVS Group plc have traded between $14.30 and $17.66 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming CVS Group plc. CVS Group plc is a $1.14B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming CVS Group plc. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for CVS Group plc. Coverage tracks CVS Group plc within Medical - Care Facilities (Healthcare). Press releases and market coverage, newest first.